innoVactiv inc. announces new findings on InSea2™: modulation of table sugar absorption. (pdf)
innoVactiv inc. announces a co-marketing agreement for InSea2™ in Europe. (pdf)
innoVactiv inc. announces the presentation of its latest human clinical study results on InSea2™ at the Experimental Biology meeting. (pdf)
innoVactiv and WEDAR consolidate their collaboration with distribution agreement for PeptiBal™ on Chinese and Taiwanese markets. (pdf)
InSea2™ new human study confirms its role as the next generation of Carb/Starch control ingredients. (pdf)
innoVactiv releases new human study results showing beneficial effects of PeptiBal™ on immune health (pdf)
innoVactiv joins forces with WEDAR Biotechnology Co. based in Taiwan to market its ingredient InSea²™in Taiwan as well as in China. (pdf)
innoVactiv’s InSea²™ is key ingredient in Enhanced Irvingia with Calorie Control product from Life Extension®. (pdf)
The company Les Biotechnologies Océanova inc. announces today that it is changing its name to innoVactiv inc. (pdf)
Les Biotechnologies Océanova inc. announces the set-up of its commercialization unit and the launch of two active ingredients from marine origin for the dietary supplements market.(pdf)
MBRC and Oceanova are teaming up in the development of a new method to produce bioactive peptides originating from marine biomasses. (available in French only)(pdf)
Nominations at Oceanova: Alain Lavoie as President of the Board and Patrice Dionne as General Manager.(available in French only)(pdf)
Les Biotechnologies Océanova inc. of Rimouski announces the launching of four active ingredients for use in cosmetics.(available in French only)(pdf)
Les Biotechnologies Océanova inc. of Rimouski is awarded the Prix d’excellence en affaires Québec-France 2006. (available in French only)(pdf)
Océanova announces the international promotion of an active ingredient of marine origin. (pdf)
